Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines
Open Access
- 14 May 2010
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 206
Abstract
Osteosarcoma (OS) is the most common primary malignant tumor of bone in children and adolescents. However, the knowledge in diagnostic modalities has progressed less. To identify new biomarkers for the early diagnosis of OS as well as for potential novel therapeutic candidates, we performed a sub-cellular comparative proteomic research.Keywords
This publication has 43 references indexed in Scilit:
- Proteomic Analysis of Chemonaïve Pediatric Osteosarcomas and Corresponding Normal Bone Reveals Multiple Altered Molecular TargetsJournal of Proteome Research, 2009
- An integrative multi-platform analysis for discovering biomarkers of osteosarcomaBMC Cancer, 2009
- Proteomics of the lysosomeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- In-Depth Proteomics to Define the Cell Surface and Secretome of Ovarian Cancer Cells and Processes of Protein SheddingCancer Research, 2009
- Global Protein-expression Analysis of Bone and Soft Tissue SarcomasClinical Orthopaedics and Related Research, 2008
- The proteome profile of the human osteosarcoma U2OS cell line.2008
- Therapy for OsteosarcomaPediatric Drugs, 2008
- Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcomaCurrent Opinion in Oncology, 2007
- Comparative proteomic analysis of human osteosarcoma and SV40-immortalized normal osteoblastic cell linesActa Pharmacologica Sinica, 2007
- Survival Data for 648 Patients with Osteosarcoma Treated at One InstitutionClinical Orthopaedics and Related Research, 2004